New oral drugs for the treatment of multiple sclerosis

被引：0
|
作者：
Chard, Declan [1 ,2 ,3 ]
Trip, Anand [1 ,2 ,3 ]
Chataway, Jeremy [1 ,2 ,3 ,4 ]
机构：
[1] UCL Inst Neurol, Queen Sq Multiple Sclerosis Ctr, Dept Neuroinflammat, London WC1N 3BG, England
[2] Univ Coll London Hosp, Natl Inst Hlth Res Biomed Res Ctr, London, England
[3] UCL, London, England
[4] UCL Inst Neurol, Neurol, London, England
来源：
BRITISH JOURNAL OF HOSPITAL MEDICINE | 2016年 / 77卷 / 09期
关键词：
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; NATALIZUMAB; TRIAL;
D O I：
10.12968/hmed.2016.77.9.502
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：502 / 503
页数：2
相关论文
共 50 条
  • [41] ORAL CYCLOPHOSPHAMIDE TREATMENT IN MULTIPLE-SCLEROSIS
    LATERRE, C
    SINDIC, CJM
    HEULE, H
    RECENT ADVANCES IN MULTIPLE SCLEROSIS THERAPY, 1989, 863 : 147 - 150
  • [42] Laquinimod, a new oral drug for multiple sclerosis
    Keegan, B. Mark
    Weinshenker, Brian G.
    LANCET, 2008, 371 (9630): : 2059 - 2060
  • [43] New forms of oral medication for multiple sclerosis
    Michiels, Yves
    Voirin, Maelle
    ACTUALITES PHARMACEUTIQUES, 2015, 54 (547): : 41 - 45
  • [44] A new oral Agent for the Therapy of multiple Sclerosis
    Borchers, Anja
    NERVENHEILKUNDE, 2011, 30 (12) : 1019 - 1019
  • [45] Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study
    Ruggieri, Serena
    Prosperini, Luca
    Al-Araji, Sarmad
    Annovazzi, Pietro Osvaldo
    Bisecco, Alvino
    Ciccarelli, Olga
    De Stefano, Nicola
    Filippi, Massimo
    Fleischer, Vinzenz
    Evangelou, Nikos
    Enzinger, Christian
    Gallo, Antonio
    Garjani, Afagh
    Groppa, Sergiu
    Haggiag, Shalom
    Khalil, Michael
    Lucchini, Matteo
    Mirabella, Massimiliano
    Montalban, Xavier
    Pozzilli, Carlo
    Preziosa, Paolo
    Rio, Jordi
    Rocca, Maria A.
    Rovira, Alex
    Stromillo, Maria L.
    Zaffaroni, Mauro
    Tortorella, Carla
    Gasperini, Claudio
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (02): : 142 - 150
  • [46] The use of immune modulating drugs for the treatment of multiple sclerosis
    Al-Khamis, Fahd A.
    NEUROSCIENCES, 2016, 21 (01) : 4 - 9
  • [47] Effectiveness of multiple sclerosis treatment with current immunomodulatory drugs
    Milo, Ron
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (05) : 659 - 673
  • [48] Extending the Potential of the Treatment of Multiple Sclerosis with a New Agent for Oral Use – Teriflunomide (Aubagio)
    Khachanova N.V.
    Gorokhova T.V.
    Neuroscience and Behavioral Physiology, 2017, 47 (1) : 112 - 116
  • [49] Laquinimod, a new oral autoimmune modulator for the treatment of relapsing-remitting multiple sclerosis
    Tselis, Alex
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (05) : 577 - 585
  • [50] New oral therapies may offer improved treatment options for patients with multiple sclerosis
    Hartung, Hans-Peter
    CURRENT OPINION IN NEUROLOGY, 2009, 22 : S10 - S14
12345